Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,005 | 8,059 | 10,085 | 15,045 | 18,650 |
| TOTAL | $6,662 | $8,956 | $11,169 | $16,426 | $19,843 |
| Non-Current Assets | |||||
| PPE Net | 202 | 251 | 309 | 367 | 425 |
| Other Non-Current Assets | 339 | 375 | 409 | 442 | 474 |
| TOTAL | $541 | $626 | $718 | $809 | $899 |
| Total Assets | $7,203 | $9,582 | $11,887 | $17,235 | $20,742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 992 | 1,025 | 1,247 | 2,315 | 2,452 |
| Accrued Expenses | 1,740 | 2,136 | 1,371 | 2,711 | 2,940 |
| TOTAL | $3,010 | $3,429 | $2,876 | $5,275 | $5,633 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,002 | 13,019 | 13,037 | 13,021 | 13,050 |
| TOTAL | $12,994 | $13,003 | $13,011 | $13,017 | $13,020 |
| Total Liabilities | $16,004 | $16,432 | $15,887 | $18,292 | $18,653 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80 | 78 | 73 | 68 | 67 |
| Common Shares | 20 | 19 | 18 | 17 | 17 |
| Retained earnings | -244,975 | -242,289 | -238,967 | -235,537 | -232,394 |
| Other shareholders' equity | -166 | 560 | 1,214 | 1,883 | 1,981 |
| TOTAL | $-8,801 | $-6,850 | $-4,000 | $-1,057 | $2,089 |
| Total Liabilities And Equity | $7,203 | $9,582 | $11,887 | $17,235 | $20,742 |